Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine Acupoint Injection for Mechanical Ventilation-Associated Gastrointestinal Dysfunction
NCT07692282Not yet recruiting
- Sponsor
- Southeast University
- Start
- Jul 2026
- Primary completion
- Feb 2028
01
Overview
Randomised trial of neostigmine in Digestive tract dysfunction (3 arms), sponsored by Southeast University. Primary endpoint: Remission rate of gastrointestinal symptoms within 24 hours. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
neostigmine
03
Conditions
Digestive tract dysfunction
Beyond the preview
Go deeper on NCT07692282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07692282.